Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients.

Flavia Maria Borges Vigil Pedro Alves Soares Vaz de Castro Ursula Gramiscelli Hasparyk Victória Soares Bartolomei Ana Cristina Dos Santos Lopes

Published in: Current medicinal chemistry (2024)

Kidney transplantation significantly improves mineral and bone disorders associated with end-stage kidney disease by modulating MBD markers and reducing bone metabolism markers, such as Dickkopf-related protein 1, osteoprotegerin, osteocalcin, osteopontin, and sclerostin. Moreover, the panel of bone biomarkers effectively predicted hypercalcemia and dyslipidemia in transplant recipients.

Keyphrases

bone mineral density
kidney transplantation
soft tissue
bone loss
bone regeneration
postmenopausal women
signaling pathway
toll like receptor
nuclear factor